Form 4: KORU Medical Systems Director Acquires Shares in Recent Transaction
SEC Form 4 Filing
Director Shahriar Matin of KORU Medical Systems, Inc. reports acquisition of 5,870 shares of common stock at $2.56 per share on April 2, 2025.
Summary
- On April 2, 2025, Shahriar Matin, a director of KORU Medical Systems, Inc., acquired 5,870 shares of common stock.
- The purchase price was $2.56 per share.
- Following the transaction, Matin directly owns 83,415 shares of KORU Medical Systems, Inc.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing a stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction could have a minor impact on shareholder sentiment, depending on how the market interprets the director's stock purchase.
Key Dates
| Date | Description |
|---|---|
| 04/02/2025 | Date of the stock transaction and filing of the SEC Form 4. |
Keywords
KORU Medical Systems, KRMD, Shahriar Matin, Director, Stock Acquisition, Beneficial Ownership, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.